Get the tools used by (smart)2 investors.

Fair Value Downside (FINBOX)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of Fair Value Downside (FINBOX)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.0%2,000.0%4,000.0%7,886.0%05001,0001,500

The chart above depicts the distribution of fair value downside (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 2,430 companies were considered in this analysis, and 2,388 had meaningful values. The average fair value downside (finbox) of companies in the sector is 303.1% with a standard deviation of 1,000.3%.

Sanofi SA's Fair Value Downside (FINBOX) of 4,982.0% ranks in the 97.6% percentile for the sector. The following table provides additional summary stats:

Fair Value Downside (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,437
Included Constituents2,388
Min0.0%
Max7,817.2%
Median0.0%
Mean303.1%
Standard Deviation1,000.3%

You can find companies with similar fair value downside (finbox) using this stock screener.

All rights reserved. Terms Of Use